Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations

The recently proposed nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease (MAFLD) has resulted in the reappraisal of epidemiological trends and associations with other chronic diseases. In this context, MAFLD appears to be tightly linked...

Descripción completa

Detalles Bibliográficos
Autores principales: Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627426/
https://www.ncbi.nlm.nih.gov/pubmed/36338895
http://dx.doi.org/10.3748/wjg.v28.i39.5691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627426/
https://www.ncbi.nlm.nih.gov/pubmed/36338895
http://dx.doi.org/10.3748/wjg.v28.i39.5691

Ejemplares similares